[go: up one dir, main page]

BRPI0509971A - uma forma de dosagem farmacêutica, comprimido e método de preparação - Google Patents

uma forma de dosagem farmacêutica, comprimido e método de preparação

Info

Publication number
BRPI0509971A
BRPI0509971A BRPI0509971-4A BRPI0509971A BRPI0509971A BR PI0509971 A BRPI0509971 A BR PI0509971A BR PI0509971 A BRPI0509971 A BR PI0509971A BR PI0509971 A BRPI0509971 A BR PI0509971A
Authority
BR
Brazil
Prior art keywords
tablet
preparation
dosage form
pharmaceutical dosage
mini tablets
Prior art date
Application number
BRPI0509971-4A
Other languages
English (en)
Inventor
Pavak R Mehta
Pasula Basavaiah Chowdary
Mailatur Sivaraman Mohan
Indu Bhushan
Kiran Krishnan
Original Assignee
Reddys Lab Inc Dr
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Inc Dr, Reddys Lab Ltd Dr filed Critical Reddys Lab Inc Dr
Publication of BRPI0509971A publication Critical patent/BRPI0509971A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UMA FORMA DE DOSAGEM FARMACêUTICA, COMPRIMIDO E MéTODO DE PREPARAçãO. Mini comprimidos compreendendo de uma substância de droga formada pela compressão, usando forças suficientemente baixas para preservar a forma polimorfa da droga. Os mini comprimidos podem ser administrados diretamente, preenchidos dentro de cápsulas, etc.
BRPI0509971-4A 2004-04-15 2005-04-14 uma forma de dosagem farmacêutica, comprimido e método de preparação BRPI0509971A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN346CH2004 2004-04-15
US60033204P 2004-08-09 2004-08-09
PCT/US2005/012544 WO2005105054A1 (en) 2004-04-15 2005-04-14 Dosage form having polymorphic stability

Publications (1)

Publication Number Publication Date
BRPI0509971A true BRPI0509971A (pt) 2007-10-02

Family

ID=40651245

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509971-4A BRPI0509971A (pt) 2004-04-15 2005-04-14 uma forma de dosagem farmacêutica, comprimido e método de preparação

Country Status (6)

Country Link
US (1) US20070224260A1 (pt)
EP (1) EP1734934A4 (pt)
BR (1) BRPI0509971A (pt)
CA (1) CA2563409A1 (pt)
WO (1) WO2005105054A1 (pt)
ZA (1) ZA200608589B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
EP1948134A2 (en) * 2005-10-17 2008-07-30 Mallinckrodt, Inc. Polymorph transformation of zolpidem in tablet matrix
WO2007054951A1 (en) * 2005-11-14 2007-05-18 Hetero Drugs Limited Process for amorphous esomeprazole
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
US20090068263A1 (en) * 2006-04-20 2009-03-12 Themis Laboratories Private Limited Multiple unit compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
DE102007037932A1 (de) * 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
WO2010018593A2 (en) * 2008-07-03 2010-02-18 Torrent Pharmaceuticals Ltd. Gastric acid resistant benzimidazole multiple unit tablet composition
CN102164576B (zh) * 2008-09-25 2013-08-28 Isp投资公司 光滑的高固体含量片剂包衣组合物
US20110177164A1 (en) * 2008-10-06 2011-07-21 Gopal Rajan Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof
WO2010086312A1 (en) * 2009-01-28 2010-08-05 Novartis Ag Galenic formulations of organic compounds
EP2366378A1 (en) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
CN102846571A (zh) * 2012-09-29 2013-01-02 南京正科制药有限公司 一种埃索美拉唑镁微型片剂
WO2020073034A1 (en) * 2018-10-05 2020-04-09 Isp Investments Llc Smooth high solids film coating composition comprising water soluble cellulose ether, process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851553A (en) * 1993-09-10 1998-12-22 Fuisz Technologies, Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
CA2448864C (en) * 2001-06-22 2008-04-22 Pfizer Products Inc. Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer
AU2002346472A1 (en) * 2001-11-20 2003-06-10 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
CA2523218A1 (en) * 2003-04-22 2004-11-04 Dr. Reddy's Laboratories Limited Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
US20050042277A1 (en) * 2003-07-17 2005-02-24 Irukulla Srinivas Pharmaceutical compositions having a swellable coating
WO2005051362A2 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
CA2552440A1 (en) * 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition

Also Published As

Publication number Publication date
ZA200608589B (en) 2007-12-27
WO2005105054A1 (en) 2005-11-10
CA2563409A1 (en) 2005-11-10
EP1734934A1 (en) 2006-12-27
US20070224260A1 (en) 2007-09-27
EP1734934A4 (en) 2012-11-14

Similar Documents

Publication Publication Date Title
BRPI0509971A (pt) uma forma de dosagem farmacêutica, comprimido e método de preparação
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
ITBO20040117A1 (it) Macchina opercolatrice e relativo metodo per la produzione di capsule sigillate
PH12015502134B1 (en) Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
PE20051127A1 (es) Comprimido multicapa de telmisartan y ramipril
CO7131367A2 (es) Formulación compuesta que comprende una tableta esferoidal de múltiples unidades (must) en cápsulada en cápsula dura y método para su preparación
EA200970267A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
WO2010127205A3 (en) Fixed dose drug combination formulations
AP2008004447A0 (en) Orally absorbed pharmaceutical formulation and method of administration
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
BRPI0418283A (pt) formulação de liberação prolongada e processo para a preparação de uma formulação de liberação prolongada
TW200744672A (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
GB2443793B (en) Product, method of manufacture and use
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BRPI0615195A8 (pt) preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida.
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
ATE508737T1 (de) Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung
AR083889A1 (es) COMPOSICION FARMACEUTICA ADAPTADA PARA ADMINISTRARSE ORALMENTE Y PROCESO PARA SU PREPARACION, PARA PREVENCION Y TRATAMIENTO DEL INTESTINO IRRITABLE A BASE DE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL Y a-D-GALACTOSIDASA
DK1858494T3 (da) Hidtil ukendte blöde gelatinekapsler
ZA200506992B (en) Fibrate tablet and method for the production thereof
EA201200727A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения
PH12014502170A1 (en) Drug composition and soft capsule drug sealing the drug composition

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.